Literature DB >> 6495639

Studies of Streptococcus suis type 2 infection in pigs.

F A Clifton-Hadley.   

Abstract

Investigations into the immunology, pathogenesis and epidemiology of Streptococcus suis type 2 infections were carried out in experimental pigs and in naturally-occurring field outbreaks of disease. The capsular polysaccharide from Str. suis type 2 was shown to induce opsonic antibodies in pigs when injected with Freund's incomplete adjuvant, but difficulties encountered in experimental production of the disease prevented a study of their protective effects. Problems with the bactericidal tests led to an investigation of other assays for antibodies against Str. suis type 2, namely, a phagocytic test with pig neutrophils, a mixed reverse passive antiglobulin haemagglutination test and an indirect haemagglutination test. There was evidence that with modifications both the latter tests would be useful. Transmission studies in 39 conventionally-reared and 7 hysterectomy-derived, colostrum-deprived pigs yielded interesting results with regard to the distribution of the organism in relation to the disease process. Tonsil carriage in clinically-healthy pigs was demonstrated after experimental and natural infection. Detectable carrier rates varied between 0 and 59%. The organism was shown to persist in the presence of circulating opsonic antibodies and in pigs on penicillin-medicated feed. Attempts to isolate the organism from the genital tract were unsuccessful. Medicated early weaning and classical SPF techniques applied to infected herds appeared to be effective in producing pigs free from Str. suis type 2 infection.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6495639     DOI: 10.1007/bf02214715

Source DB:  PubMed          Journal:  Vet Res Commun        ISSN: 0165-7380            Impact factor:   2.459


  24 in total

1.  The serological classification of streptococci isolated from diseased pigs.

Authors:  J E Jones
Journal:  Br Vet J       Date:  1976 Mar-Apr

2.  The class of antibodies sensitizing bacteria measured by mixed reverse passive antiglobulin haemagglutination (MRPAH).

Authors:  R R Coombs; L Edebo; A Feinstein; B W Gurner
Journal:  Immunology       Date:  1978-06       Impact factor: 7.397

3.  Streptococcal infection in young pigs. 3. The immunity of adult pigs investigated by the bactericidal test.

Authors:  K K Agarwal; S D Elliott; P J Lachmann
Journal:  J Hyg (Lond)       Date:  1969-09

4.  The isolation of Streptococcus suis type II from a pig with meningitis.

Authors:  J R Buddle; J E Jones; D A Pass; J Robertson
Journal:  Aust Vet J       Date:  1981-09       Impact factor: 1.281

5.  Meningitis in pigs caused by Streptococcus suis type II.

Authors:  R S Windsor
Journal:  Vet Rec       Date:  1977-11-05       Impact factor: 2.695

6.  [Pork-butcher's meningitis].

Authors:  J P Ancelle; G Paul; G Lionsguy; C Brochard; R Brassac; P Névot
Journal:  Nouv Presse Med       Date:  1977-11-26

7.  Streptococcal infection in young pigs. IV. An outbreak of streptococcal meningitis in weaned pigs.

Authors:  R S Windsor; S D Elliott
Journal:  J Hyg (Lond)       Date:  1975-08

8.  [R and S-streptococcal infections in swine].

Authors:  E Kunter; W Wittig
Journal:  Arch Exp Veterinarmed       Date:  1976

9.  Lancefield group R streptococci associated with pneumonia in swine.

Authors:  G Koehne; R L Maddux; W D Cornell
Journal:  Am J Vet Res       Date:  1979-11       Impact factor: 1.156

10.  The type-specific polysaccharides of Streptococcus suis.

Authors:  S D Elliott; J Y Tai
Journal:  J Exp Med       Date:  1978-12-01       Impact factor: 14.307

View more
  11 in total

1.  Streptococcus suis isolated from pigs in Finland.

Authors:  L Sihvonen; D N Kurl; J Henrichsen
Journal:  Acta Vet Scand       Date:  1988       Impact factor: 1.695

2.  Decrease of the adhesion of Streptococcus suis serotype 2 mutants to embryonic bovine tracheal cells and porcine tracheal rings.

Authors:  J Brassard; M Gottschalk; S Quessy
Journal:  Can J Vet Res       Date:  2001-07       Impact factor: 1.310

3.  The galactosyl-(alpha 1-4)-galactose-binding adhesin of Streptococcus suis: occurrence in strains of different hemagglutination activities and induction of opsonic antibodies.

Authors:  K Tikkanen; S Haataja; J Finne
Journal:  Infect Immun       Date:  1996-09       Impact factor: 3.441

Review 4.  Streptococcus suis: past and present.

Authors:  J J Staats; I Feder; O Okwumabua; M M Chengappa
Journal:  Vet Res Commun       Date:  1997-08       Impact factor: 2.459

5.  Streptococcus suis in slaughter pigs and abattoir workers.

Authors:  J Breton; W R Mitchell; S Rosendal
Journal:  Can J Vet Res       Date:  1986-07       Impact factor: 1.310

6.  A longitudinal study of natural infection of piglets with Streptococcus suis types 1 and 2.

Authors:  I D Robertson; D K Blackmore; D J Hampson; Z F Fu
Journal:  Epidemiol Infect       Date:  1991-08       Impact factor: 2.451

7.  Prevalence of Streptococcus suis in four to eight week old clinically healthy piglets.

Authors:  L M Brisebois; R Charlebois; R Higgins; M Nadeau
Journal:  Can J Vet Res       Date:  1990-01       Impact factor: 1.310

8.  Antibacterial mechanism of rhodomyrtone involves the disruption of nucleoid segregation checkpoint in Streptococcus suis.

Authors:  Apichaya Traithan; Pongsri Tongtawe; Jeeraphong Thanongsaksrikul; Supayang Voravuthikunchai; Potjanee Srimanote
Journal:  AMB Express       Date:  2020-06-08       Impact factor: 3.298

9.  The Phage Lysin PlySs2 Decolonizes Streptococcus suis from Murine Intranasal Mucosa.

Authors:  Daniel B Gilmer; Jonathan E Schmitz; Mya Thandar; Chad W Euler; Vincent A Fischetti
Journal:  PLoS One       Date:  2017-01-03       Impact factor: 3.240

10.  Serotype and Genotype (Multilocus Sequence Type) of Streptococcus suis Isolates from the United States Serve as Predictors of Pathotype.

Authors:  April A Estrada; Marcelo Gottschalk; Stephanie Rossow; Aaron Rendahl; Connie Gebhart; Douglas G Marthaler
Journal:  J Clin Microbiol       Date:  2019-08-26       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.